Inogen Inc INGN

$7.02 +0.15 (2.18%)

Valuation

Market cap
182,316,000
Revenue TTM
$348,670,000
Net income TTM
$-22,750,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-6.52%
Debt to equity
0.00

Trading

Volume
201,800
Avg volume
315,104
Day's range
$6.74 – $7.04
Shares out
26,538,000
Stochastic %K
50%
Beta
1.51
Analysts
Strong Buy
Price target
$12.00

Price

Company profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a porta...

Show more

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
805 562 0500
Website
https://www.provider.inogen.com
Address
500 Cummings Center, Suite 2800, Beverly, United States

Latest news

Stocktwits

focafoca99 Oct 15, 5:17 PM
$INGN outlines its upcoming Q3 2026 earnings release on Nov 5.
0 replies
JuliaWarhol15 Oct 7, 1:15 PM
$INGN Fall allergy season and Flu season upon us(a)... COPD admissions are on the rise. POC orders are up. Go INGN
0 replies
KUMO2026 Oct 1, 4:21 PM
$INGN swing trade to 6.26
0 replies
KryptonResearch14 Oct 1, 2:58 PM
$INGN Inogen is selling its US oxygen rental business to Rotech Healthcare for up to $25 million cash, expected to close in Q4 (company release, Sept 30). The structure is the interesting part. Rotech buys the rental assets and signs a long-term supply deal to push Inogen's concentrators through its national distribution network. Inogen sheds the capital-intensive rental business but keeps the hardware relationship with its buyer. The math it cleans up: rental revenue was $24.3M in the first half, down 9.8% YoY. Starting Q3 it moves to discontinued operations, which mechanically lifts the reported growth and margins of the remaining business. Contingent on closing, the board raised the buyback authorization $15M to $45M.
0 replies
DonCorleone77 Oct 1, 12:03 AM
$BSET $GLUE $VICR $INGN $NU AFTER-HOURS MOVERS: Currently Higher After Earnings: - Bassett Furniture Industries (BSET) up 9.9% Currently Also Higher: - Monte Rosa Therapeutics (GLUE) up 17.1% after announcing presentation of MRT-8102 GFORCE-1 Phase 1 Study - Vicor (VICR) up 9.7% after Q3 pre-announcement - Inogen (INGN) up 7.7% after announcing plans to divest U.S. oxygen rental business and increase buyback - Nu Holdings Ltd. (NU) up 6.1% after denying reports of Monzo transaction - Rogers (ROG) up 1.2% after medium-term outlook - Micron Technology (MU) up 0.4% Currently Lower After Earnings: - Progress Software (PRGS) down 0.2%
1 replies
Yingtrader7 Sep 26, 7:51 PM
$NSYS holy shilajit why is $INGN so cheap OMG
0 replies
opgntozero Sep 2, 6:45 PM
$INGN is showing real signs of a turnaround. Q2 2026 revenue reached $95.1M (~RMB 642M), while Adjusted EBITDA was positive $2.4M. With $106.8M (~RMB 718M) in cash and no debt, the balance sheet adds serious optionality https://x.com/aktienboersen/status/2095221144617972147
0 replies
Estimize Aug 13, 8:03 PM
Wall St is expecting 0.01 EPS for $INGN Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_co
0 replies